BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Vivimed Labs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -20.74 | 5.13 | 8.85 | 173.39 | 11.34 | |
| Net CashFlow From Operating Activities | 75.02 | 82.04 | 206.55 | 28.17 | -54.21 | |
| Net Cash Used In Investing Activities | 3.32 | 56.17 | -38.12 | 29.83 | -11.15 | |
| Net Cash Used From Financing Activities | -91.42 | -123.23 | -174.81 | -49.62 | 58.54 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -13.07 | 14.98 | -6.38 | 8.38 | -6.82 | |
| Cash And Cash Equivalents Begin of Year | 24.16 | 9.18 | 15.56 | 7.18 | 14.00 | |
| Cash And Cash Equivalents End Of Year | 11.09 | 24.16 | 9.18 | 15.56 | 7.18 |
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y